GleamWall
中文EN

ENOV Enovis CORP

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1420800 · Fiscal year ends 12/31

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY3.3%
TTM net income YoY61.4%
TTM EPS YoY62.1%
Revenue 3-yr CAGR11.6%
Net income 3-yr CAGR—

Margins

Gross margin61.3%
Operating margin-20.6%
Net margin-22.9%
FCF margin3.0%
EBITDA margin37.7%

Returns

ROE-30.0%
ROA-12.9%
ROIC (approx.)-12.3%
Asset turnover0.56x

Leverage & solvency

Liabilities / assets60.0%
Debt / equity0.84x
Current ratio2.15x
Interest coverage-14.69x

Cash quality & payout

Operating cash flow / net income-0.49x
Accruals ratio-19.3%
Payout ratio—
Capex / revenue8.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.25B$2.11B
Cost of revenue$902.79M$926.87M
Gross profit$1.35B$1.18B
R&D expense$120.33M$91.30M
SG&A expense$1.07B$1.03B
Operating income-$1.12B-$775.72M
Interest expense$34.82M$57.10M
Pretax income-$1.16B-$822.92M
Income tax$22.29M$4.49M
Net income-$1.18B-$825.49M
EBITDA$219.89M$152.11M
EPS (basic)-20.75-14.93
EPS (diluted)-20.75-14.93
Weighted avg. shares (diluted)57.07M55.28M
Balance sheet
Cash & equivalents$36.39M$48.17M
Receivables$442.79M$407.03M
Inventory$584.38M$547.12M
Current assets$1.21B$1.15B
PP&E, net$507.06M$404.50M
Goodwill$718.30M$1.69B
Intangibles$1.24B$1.32B
Total assets$3.83B$4.72B
Current liabilities$598.47M$529.00M
Short-term debt$35.00M$20.03M
Long-term debt$1.26B$1.31B
Total debt$1.30B$1.33B
Total liabilities$2.34B$2.15B
Shareholders' equity$1.49B$2.56B
Net debt$1.26B$1.28B
Shares outstanding57.19M55.88M
Cash flow statement
Operating cash flow$217.29M$113.50M
Capital expenditure$197.38M$180.71M
Free cash flow$19.92M-$67.21M
Investing cash flow-$179.37M-$955.47M
Financing cash flow-$52.40M$846.82M
Depreciation & amortization$1.34B$927.83M
Stock-based compensation$32.92M$29.66M
Share buybacks$3.50M$4.77M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.